Our preclinical data argue strongly for a tumor promoting role of a signaling axis emanating from IL-11-induced, tumor cell-derived IL-33 and the subsequent hierarchical activation cascade of mast cells and tumor-associated macrophages. This evidence concerns the gene IL11 and neoplasm.